Is there a case for MDMA-assisted psychotherapy in the UK?
Journal of Psychopharmacology – February 28, 2007
Source: OpenAlex
Summary
MDMA, often viewed through the lens of recreational risks, has a compelling history as an effective therapeutic tool in psychotherapy. Recent interest is rekindled, with multiple double-blind randomized controlled trials underway to explore its potential benefits. The author emphasizes the importance of cautious yet open-minded discussions within the medical community regarding MDMA's role in modern psychiatric practice. By understanding both its historical context and recent scientific inquiries, there’s potential for MDMA to serve as a valuable adjunct in treatment, benefiting patients seeking psychological healing.
Abstract
Much has been written in scientific and popular literature in recent years about the dangers surrounding the recreational use of the drug MDMA/ecstasy. What is little known and understood however is the history of the apparently safe and effective use of MDMA as a therapeutic tool for psychotherapy. In this paper the author explores this history and describes the recent re-emergence of scientific interest in MDMA and other psychedelic drugs. There are currently several new double-blind randomised controlled trials underway re-visiting the subject. By acknowledging the limitations of this new research and emphasising the importance of exercising appropriate but realistic caution, the author asks that the medical profession consider a dispassionate and open-minded debate to examine whether MDMA might have a legitimate place as an adjunct to psychotherapy in modern psychiatric practice.